Bristol Myers Squibb Announces Dividend

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-two cents ($0.62) per share on the $0.10 par value common stock of the company. The dividend is payable on November 3, 2025, to stockholders of record at the close of business on October 3, 2025.

In addition, the Board of Directors has declared a quarterly dividend of fifty cents ($0.50) per share on the company’s $2.00 convertible preferred stock, payable on December 1, 2025, to stockholders of record at the close of business on November 4, 2025.

About Bristol Myers Squibb: Transforming Patients’ Lives Through Science

At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com and follow us on LinkedIn, X, YouTube, Facebook and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20250917900950/en/

For more information, contact:

Media Relations:
[email protected]

Investor Relations:
[email protected]

Source: Bristol Myers Squibb

You May Also Be Interested In

• e.l.f. Cosmetics Answers Community Demand with the Return of Pickle-Inspired Glow Reviver Melting Lip Balms
• PINSPARK Celebrates National Golf Month with High-Performance UPF 50+ Golf Collection – Summer Style on the Course for Men and Women
• 12B SPORTS and VR46 Racing Team Bring Sung Kang into the World of MotoGP